Ebola virus disease
ST Jacob, I Crozier, WA Fischer, A Hewlett… - Nature reviews Disease …, 2020 - nature.com
Ebola virus disease (EVD) is a severe and frequently lethal disease caused by Ebola virus
(EBOV). EVD outbreaks typically start from a single case of probable zoonotic transmission …
(EBOV). EVD outbreaks typically start from a single case of probable zoonotic transmission …
Ebola virus disease
D Malvy, AK McElroy, H de Clerck, S Günther… - The Lancet, 2019 - thelancet.com
Ebolaviruses are pathogenic agents associated with a severe, potentially fatal, systemic
disease in man and great apes. Four species of ebolaviruses have been identified in west or …
disease in man and great apes. Four species of ebolaviruses have been identified in west or …
Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks
AK Keita, FR Koundouno, M Faye, A Düx, J Hinzmann… - Nature, 2021 - nature.com
Seven years after the declaration of the first epidemic of Ebola virus disease in Guinea, the
country faced a new outbreak—between 14 February and 19 June 2021—near the …
country faced a new outbreak—between 14 February and 19 June 2021—near the …
The factors affecting household transmission dynamics and community compliance with Ebola control measures: a mixed-methods study in a rural village in Sierra …
G Caleo, J Duncombe, F Jephcott, K Lokuge, C Mills… - BMC public health, 2018 - Springer
Background Little is understood of Ebola virus disease (EVD) transmission dynamics and
community compliance with control measures over time. Understanding these interactions is …
community compliance with control measures over time. Understanding these interactions is …
[HTML][HTML] Ebola virus disease: An emerging and re-emerging viral threat
The genus Ebolavirus from the family Filoviridae is composed of five species including
Sudan ebolavirus, Reston ebolavirus, Bundibugyo ebolavirus, Taï Forest ebolavirus, and …
Sudan ebolavirus, Reston ebolavirus, Bundibugyo ebolavirus, Taï Forest ebolavirus, and …
Exit and entry screening practices for infectious diseases among travelers at points of entry: Looking for evidence on public health impact
VA Mouchtouri, EP Christoforidou… - International journal of …, 2019 - mdpi.com
A scoping search and a systematic literature review were conducted to give an insight on
entry and exit screening referring to travelers at points of entry, by analyzing published …
entry and exit screening referring to travelers at points of entry, by analyzing published …
Ebola virus transmission caused by persistently infected survivors of the 2014–2016 outbreak in West Africa
L Subissi, M Keita, S Mesfin, G Rezza… - The Journal of …, 2018 - academic.oup.com
Abstract The 2014–2016 Ebola virus (EBOV) disease outbreak affected over 29000 people
and left behind the biggest cohort (over 17000 individuals) of Ebola survivors in history …
and left behind the biggest cohort (over 17000 individuals) of Ebola survivors in history …
Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study
R Thom, T Tipton, T Strecker, Y Hall… - The Lancet Infectious …, 2021 - thelancet.com
Summary Background The 2013–16 Ebola virus disease epidemic in west Africa caused
international alarm due to its rapid and extensive spread resulting in a significant death toll …
international alarm due to its rapid and extensive spread resulting in a significant death toll …
Viral genomics in Ebola virus research
N Di Paola, M Sanchez-Lockhart, X Zeng… - Nature Reviews …, 2020 - nature.com
Filoviruses such as Ebola virus continue to pose a substantial health risk to humans.
Advances in the sequencing and functional characterization of both pathogen and host …
Advances in the sequencing and functional characterization of both pathogen and host …
Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled …
MD Tapia, SO Sow, BP Ndiaye, KD Mbaye… - The Lancet Infectious …, 2020 - thelancet.com
Summary Background The 2014 Zaire Ebola virus disease epidemic accelerated vaccine
development for the virus. We aimed to assess the safety, reactogenicity, and …
development for the virus. We aimed to assess the safety, reactogenicity, and …